SIGA technologies’ TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
On Jan. 2, 2025, SIGA Technologies announced that its antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as…
On Jan. 2, 2025, SIGA Technologies announced that its antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as…